Pre-eclampsia is a disorder that occurs only during pregnancy and the postpartum period and affects both the mother and the fetus. That affects at least 5-8% of all pregnancies, is rapidly progressive which is characterized by high blood pressure and the presence of protein in the urine. Swelling, sudden increase in weight, headaches and vision changes are important symptoms, but some women with the disease progresses rapidly report few symptoms.
In general, pre-eclampsia occurs after 20 weeks of gestation (in the late 2 nd and 3 rd quarter in mid or late pregnancy), but may occur sooner. Good prenatal care is essential to diagnose and treat preeclampsia. Preeclampsia, hypertension induced by pregnancy (PIH), toxaemia and conditions are closely related. HELLP Syndrome and eclampsia are other manifestations of the same syndrome. It is important to note that research shows that a larger number of women who die from pre-eclampsia and eclampsia one is not necessarily worse than the other.
Preeclampsia and other hypertensive disorders of pregnancy are the leading cause of maternal and infant illness and death. By conservative estimates, these disorders are responsible for 76000 deaths each year.
Subscribe to:
Post Comments (Atom)
1 comments:
Premature births and maternal distress related to hypertension and preeclampsia can result in over 10,000 infant deaths and up to $5 billion in annual health care costs in the U.S. But a recent medical breakthrough can alleviate both the worry of infant death and the cost of this expensive health concern. David Chaffin, MD, and Denise G. Webb, CRNP developed MIST in 2002 at the Marshall University's Maternal Hypertension Center through Cabell Huntington Hospital in Huntington, WV, conducting clinical evaluations with results showing a 50% reduction in preeclampsia and zero maternal and infant mortalities in treating over 1400 at risk women. Visit http://www.misttechnologies.com/ for more information and start asking your doctor for your MIST test today.
Post a Comment